Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®*, its Third Approved Biosimilar in the U.S.
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Over the past five decades, numerous oxygen sensing technologies have been developed, with solid-state zirconia and elec…
Pirmasens, Germany, April 10, 2024. More recycling polyol, less CO2: RAMPF Eco Solutions is presenting high-quality recy…
VG901 is the first and only clinical-stage therapy designed to deliver a functional CNGA1 gene to retinal photoceptor t…
ANDAAS and its partners together with NUM, developed an innovative High Speed 5-Axis Milling Machines; using the well-kn…
- Recce wurde von der Innovationsagentur der Regierung des Vereinigten Königreichs als eine der vielversprec…
CeGaT, a global provider of genetic diagnostics and sequencing services based in Tübingen, Germany, is celebrating sever…
Within the realm of modern technology, cameras have progressed from mere devices capturing visible light to sophisticate…
Heute startet die DMEA 2024 und rückt die Kernthemen der Digitalisierung des Gesundheitswesens in den Fokus. Mehr als 32…
BSI Life Sciences announces Harmony Clinical Research (HarmonyCR) as the latest client to adopt its cloud-based electron…